Log In
Print
BCIQ
Print
Print this Print this
 

IC14

  Manage Alerts
Collapse Summary General Information
Company Implicit Biosciences Pty. Ltd.
DescriptionRecombinant chimeric mAb against CD14
Molecular Target CD14
Mechanism of ActionBinds CD14
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationAcute lung injury
Indication DetailsTreat acute lung injury
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today